ICU中无代理决策患者医疗决策的制定:美国胸科学会/美国老年医学会官方政策声明
该多学会政策声明针对ICU中缺乏决策能力、无适用预立医嘱且无可用代理决策者的「无代理」患者,由跨专业多学科专家委员会采用迭代共识流程制定。委员会提出五项伦理目标:保护高危患者、尊重个人、提供适当医疗、防止不可接受的歧视、避免竞争性义务与利益冲突的不当影响,并给出6条推荐:机构应提供预立照护规划以预防高危患者成为无代理;应实施策略确认看似无代理者是否确实无代理,包括仔细评估决策能力和努力寻找潜在代理者;应使用多元跨专业多学科委员会的意见而非由治疗医生临时决策;应利用患者偏好与价值观的所有可用信息指导决策;应使用符合程序正当程序的公平程序;即使州法律授权监督较少的程序也应采用该公平程序。
要点
- 机构应实施策略确认看似无代理的患者是否确实无代理,包括仔细的决策能力评估和努力寻找潜在代理决策者。
- 机构应使用多元跨专业、多学科委员会的意见管理无代理患者的决策,而非由治疗医生临时决定。
- 机构应利用患者偏好与价值观的所有可用信息指导无代理患者的治疗决策。
- 机构应使用符合程序正当程序的公平程序管理无代理患者的决策,即使州法律授权监督较少的程序也应采用。
- 机构应向成为无代理高风险的患者提供预立照护规划以预防其符合无代理定义。
适用人群与场景
- ICU中缺乏决策能力、无适用预立医嘱且无可用代理决策者的患者(称为「无代理」患者)。
- 适用于危重症医疗场景中的临床医生和医院管理者。
处置流程与药物剂量
- 机构应向成为无代理高风险的患者提供预立照护规划,以预防其符合无代理定义。
- 机构应实施策略确定看似无代理的患者是否确实无代理,包括仔细的决策能力评估和努力寻找潜在代理决策者。
- 机构应使用多元跨专业、多学科委员会的意见管理无代理患者的决策,而非由治疗医生临时决定。
- 机构应使用患者偏好与价值观的所有可用信息指导治疗决策。
- 机构应使用符合程序正当程序的公平程序管理无代理患者的决策。
- 机构即使州法律授权监督较少的程序,也应采用该公平程序。
研究设计与关键结果
- 该政策声明由跨专业多学科专家委员会采用迭代共识流程制定,工作组成员代表重症医学、姑息治疗、儿科医学、护理、社会工作、老年学、老年医学、患者倡导、生物伦理、哲学、老年法及卫生法。
- 委员会设计推荐以促进五项伦理目标:保护高度脆弱患者、展示对个人的尊重、提供适当医疗、防止不可接受的歧视、避免竞争性义务与冲突利益的不当影响。
- 推荐旨在在过度与不足的程序保障之间取得适当平衡。
证据类型、等级与局限
- 证据类型:多学会政策声明(指南/共识),由美国胸科学会/美国老年医学会发布,采用迭代共识流程制定。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,机构应使用多元跨专业多学科委员会而非治疗医生临时决策来处理无代理患者的决策,以保护高度脆弱患者并防止不可接受的歧视。
- 作者认为,机构应实施策略确认看似无代理者是否确实无代理,包括仔细的决策能力评估和努力寻找潜在代理者,并利用患者偏好与价值观的所有可用信息指导决策。
- 作者认为,机构应使用符合程序正当程序的公平程序,即使州法律授权监督较少的程序也应采用。
指南或共识出处
- 美国胸科学会/美国老年医学会政策声明:ICU中无代理决策患者医疗决策的制定(Making Medical Treatment Decisions for Unrepresented Patients in the ICU),发表于American Journal of Respiratory and Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background and Rationale: ICU clinicians regularly care for patients who lack capacity, an applicable advance directive, and an available surrogate decision-maker. Although there is no consensus on terminology, we refer to these patients as "unrepresented." There is considerable controversy about how to make treatment decisions for these patients, and there is significant variability in both law and clinical practice.Purpose and Objectives: This multisociety statement provides clinicians and hospital administrators with recommendations for decision-making on behalf of unrepresented patients in the critical care setting.Methods: An interprofessional, multidisciplinary expert committee developed this policy statement by using an iterative consensus process with a diverse working group representing critical care medicine, palliative care, pediatric medicine, nursing, social work, gerontology, geriatrics, patient advocacy, bioethics, philosophy, elder law, and health law.Main Results: The committee designed its policy recommendations to promote five ethical goals: 1) to protect highly vulnerable patients, 2) to demonstrate respect for persons, 3) to provide appropriate medical care, 4) to safeguard against unacceptable discrimination, and 5) to avoid undue influence of competing obligations and conflicting interests. These recommendations also are intended to strike an appropriate balance between excessive and insufficient procedural safeguards. The committee makes the following recommendations: 1) institutions should offer advance care planning to prevent patients at high risk for becoming unrepresented from meeting this definition; 2) institutions should implement strategies to determine whether seemingly unrepresented patients are actually unrepresented, including careful capacity assessments and diligent searches for potential surrogates; 3) institutions should manage decision-making for unrepresented patients using input from a diverse interprofessional, multidisciplinary committee rather than ad hoc by treating clinicians; 4) institutions should use all available information on the patient's preferences and values to guide treatment decisions; 5) institutions should manage decision-making for unrepresented patients using a fair process that comports with procedural due process; 6) institutions should employ this fair process even when state law authorizes procedures with less oversight.Conclusions: This multisociety statement provides guidance for clinicians and hospital administrators on medical decision-making for unrepresented patients in the critical care setting.
参考来源
- Pope TM, Bennett J, Carson SS, et al. Making Medical Treatment Decisions for Unrepresented Patients in the ICU. An Official American Thoracic Society/American Geriatrics Society Policy Statement. Am J Respir Crit Care Med. 2020. PMID: 32412853. doi:10.1164/rccm.202003-0512ST
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。